Gene Therapy in Parkinson's Disease: Rationale and Current Status

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.3, 2010-03, pp. : 177-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for Parkinson's Disease: Current Status and Future Potential

By Segovia J.

American Journal of PharmacoGenomics, Vol. 2, Iss. 2, 2002-01 ,pp. : 135-146

Adis International

Access to resources Recommend Favorite

Gene Therapy in Cardiovascular Disease: Current Status

By Francis S.C.

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 55-66

Adis International

Access to resources Recommend Favorite

Rationale for current therapies in Parkinson’s disease

By Romrell Janet Fernandez Hubert H Okun Michael S

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1747-1761

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives

Current Gene Therapy, Vol. 14, Iss. 6, 2014-12 ,pp. : 447-460

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Restenosis: Current Status

By Rutanen J.

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1575-1585

Adis International

Access to resources Recommend Favorite